search icon

    Market Snapshot

    • S&P Futures

      3,809.5

    • Dow Futures

      30,868

    • Nasdaq Futures

      11,633.25

    blog search icon

    Athersys, Inc.

    (NASDAQ:ATHX)

    $0.26

    $-0.03

    -9.12%

    Athersys, Inc. Chart

    ATHX Stock Price Today

    Athersys, Inc. (ATHX) stock declined over -9.12% intraday to trade at $0.26 a share on NASDAQ. The stock opened with a gain of 0.00% at $0.276 and touched an intraday high of $0.28, falling -10.34% against the last close of $0.29. The stock went to a low of $0.25 during the session.

    Stock Snapshot

    $0.29

    Prev. Close

    72.19 Million

    Market Cap

    $0.25

    Day Low

    $0.276

    Open

    244.2 Million

    Number of Shares

    $0.28

    Day High

    -

    P/E ratio

    -0.35

    EPS (TTM)

    0.15

    Cash Flow per Share

    14.11

    Free Float in %

    0.12

    Book Value

    3,363,131

    Volume

    Athersys, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-30$0.276$0.28$0.25$0.263,368,831
    2022-06-29$0.26$0.33$0.26$0.299,785,000
    2022-06-28$0.26$0.28$0.26$0.264,476,100
    2022-06-27$0.25$0.27$0.24$0.274,060,700
    2022-06-24$0.27$0.27$0.25$0.2526,348,200
    2022-06-23$0.25$0.28$0.25$0.286,944,400
    2022-06-22$0.25$0.27$0.23$0.268,341,400
    2022-06-21$0.3$0.3$0.26$0.2612,486,700
    2022-06-17$0.4$0.42$0.28$0.2840,428,000
    2022-06-16$0.37$0.37$0.32$0.323,327,900

    Contact Details

    3201 Carnegie Avenue
    Cleveland, OH 44115-2634
    United States

    Webiste:ATHX

    216 431 9900

    Company Information

    Employees-

    Beta-1.35

    Sales or Revenue5.51 Million

    5Y Sales Change-20.50%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product includes MultiStem cell therapy, an allogeneic stem cell product, which is in Phase III clinical study for the treatment of patients suffering from neurological damage from an ischemic stroke, as well as for acute respiratory distress syndrome, trauma complications, HSC transplant support, and other indications. It also develops MultiStem cell therapy to promote tissue repair and healing for animal patients, including those suffering from serious conditions with unmet medical needs. The company has license and collaboration agreements with Healios K.K. to develop and commercialize MultiStem cell therapy for ischemic stroke, acute respiratory distress syndrome, and ophthalmological indications, as well as for the treatment of liver, kidney, pancreas, and intestinal tissue diseases; and the University of Minnesota to develop MultiStem cell therapy platform. Athersys, Inc. was founded in 1995 and is headquartered in Cleveland, Ohio.

    Frequently Asked Questions

    icon

    What is the current Athersys, Inc. (ATHX) stock price?

    Athersys, Inc. (NASDAQ: ATHX) stock price is $0.26 as of the last check on Thursday, June 30. During the trading session, ATHX stock reached the peak price of $0.28 while $0.25 was the lowest point it dropped to.

    icon

    ATHX's industry and sector of operation?

    The NASDAQ listed ATHX is part of Biotechnology industry that operates in the broader Health Care sector. Athersys, Inc. , a biotechnology company, focuses on the research and development activities in the field of regenerative medicine.

    icon

    Who are the executives of ATHX?

    Mr. William B. J. Lehmann Jr., M.B.A., J.D., MBA
    Pres, COO, Sec. & Interim CEO
    Dr. Eric Jenkins M.D.
    Sr. Medical Director & Head of Clinical Operations
    Mr. William Lehmann Jr., J.D., M.B.A., MBA
    Pres, COO & Sec.
    Dr. John J. Harrington Ph.D.
    Co-Founder, Chief Scientific Officer, Exec. VP & Director

    icon

    What is the ATHX stock price today?

    ATHX stock traded closed the last session at $0.26, which is $-0.03 or -9.12% lower than its previous close of $0.29. ATHX's current trading price is 44.44% lower than its 52-week high of $1.81 where as its distance from 52-week low of 0.18% is -85.64%.

    icon

    How many employees does ATHX have?

    Number of ATHX employees currently stands at -. ATHX operates from 3201 Carnegie Avenue, Cleveland, OH 44115-2634, United States.

    icon

    Link for ATHX official website?

    Official Webiste of $ATHX is: https://www.athersys.com

    icon

    How do I contact ATHX?

    ATHX could be contacted at ATHX operates from 3201 Carnegie Avenue, Cleveland, OH 44115-2634, United States, or at phone #216 431 9900 and can also be accessed through its website.

    icon

    How many shares of ATHX are traded daily?

    ATHX stock volume for the day was 3,363,131 shares while in the previous session number of ATHX shares traded was 3,368,831 . The average number of ATHX shares traded daily for last 3 months was 7.12 Million.

    icon

    How much did ATHX change today?

    The percentage change in ATHX stock occurred in the recent session was -9.12% while the dollar amount for the price change in ATHX stock was $-0.03.

    icon

    What price range ATHX stock been trading in?

    In the recent session, the day high for ATHX stock was $0.28 while the low for ATHX stock touched on the day was $0.25.

    icon

    What is the market cap of ATHX currently?

    The market value of ATHX currently stands at 72.19 Million with its latest stock price at $0.26 and 244.2 Million of its shares outstanding.